{"ok":true,"entity":{"id":"mhra","name":"MHRA (Medicines and Healthcare products Regulatory Agency)","entityType":"organization","officialName":"Medicines and Healthcare products Regulatory Agency","canonicalName":"MHRA (Medicines and Healthcare products Regulatory Agency)","displayName":"MHRA (Medicines and Healthcare products Regulatory Agency)","category":"英国の医薬品・医療機器規制当局","shortDescription":"MHRA（Medicines and Healthcare products Regulatory Agency）は、英国で医薬品、医療機器、輸血用血液成分を規制する、保健社会福祉省（DHSC）が所管する執行機関です。2026年10月時点でChief ExecutiveはLawrence Tallon氏、ChairはAnthony Harnden教授とされ、2026年10月14日に「MHRA 2030 Strategy」を公表しました。","primaryCluster":"healthcare","parentEntity":null,"verificationStatus":"draft","website":"https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency","updatedAt":"2026-10-22T11:50:32.298Z","secondaryClusters":[],"alias":["Medicines and Healthcare products Regulatory Agency","英国医薬品・医療製品規制庁"],"searchKeywords":["MHRA","Medicines and Healthcare products Regulatory Agency","英国医薬品・医療製品規制庁","エムエイチアールエー","英国 規制当局","医薬品規制 英国","医療機器規制 英国","MHRA 2030 Strategy"]},"referenceIndex":["P-01-001","P-02-001","P-04-001","P-05-001","P-06-001"]}